Effects of 6-months treatment with donepezil and rivastigmin on results of neuropsychological tests in patients with Alzheimer's disease

被引：0
|
作者：
Abolfazli, R.
Nazeman, M.
Ghazanshahi, S.
Taebei, H.
机构：
[1] Univ Tehran Med Sci, Tehran, Iran
[2] Shaheed Beheshti Univ Med Sci, Tehran, Iran
来源：
JOURNAL OF NEUROLOGY | 2007年 / 254卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [11] Donepezil for the treatment of agitation in Alzheimer's disease
    Howard, Robert J.
    Juszczak, Edmund
    Ballard, Clive G.
    Bentham, Peter
    Brown, Richard G.
    Bullock, Roger
    Burns, Alistair S.
    Holmes, Clive
    Jacoby, Robin
    Johnson, Tony
    Knapp, Martin
    Lindesay, James
    O'Brien, John T.
    Wilcock, Gordon
    Katona, Cornelius
    Jones, Roy W.
    DeCesare, Julia
    Rodger, Michaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1382 - 1392
  • [12] Transdermal donepezil on the treatment of Alzheimer's disease
    Sozio, Piera
    Cerasa, Laura S.
    Marinelli, Lisa
    Di Stefano, Antonio
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 361 - 368
  • [13] Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
    Cummings, Jeffrey L.
    Schneider, Eugene
    Tariot, Pierre N.
    Graham, Stephen M.
    NEUROLOGY, 2006, 67 (01) : 57 - 63
  • [14] Effects of donepezil on liver and kidney functions for the treatment of Alzheimer's disease
    Erbayraktar, Zubeyde
    Evlice, Ahmet
    Yener, Gorsev
    Ulusu, N. Nuray
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2017, 16 (03) : 335 - 346
  • [15] Treatment benefits of donepezil in patients with severe Alzheimer's disease and their caregivers
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Ieni, J
    Xu, Y
    Schwam, E
    NEUROLOGY, 2005, 64 (06) : A105 - A105
  • [16] Long-term donepezil treatment in patients with Alzheimer’s disease
    Andrew Kertesz
    Current Neurology and Neuroscience Reports, 2004, 4 (6) : 459 - 460
  • [17] Behavioral benefits with continued donepezil treatment in Alzheimer's disease patients
    Johanssen, P.
    Hasselbalch, S.
    Jakab, G.
    Kalisvaart, C. J.
    Kozubski, W.
    Kurz, A.
    McCarthy, J.
    Triau, E.
    Tsolaki, M.
    Qvitzau, S.
    Richardson, S.
    Xu, Y.
    Schwam, E.
    Schindler, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 184 - 184
  • [18] Behavioral benefits with continued donepezil treatment in Alzheimer's disease patients
    Johannsen, P
    Holub, R
    Jakab, G
    Jakobsen, S
    Kalisvaart, CJ
    Kozubski, W
    Kurz, A
    Triau, E
    Tsolaki, M
    Bergendorff, L
    Xu, Y
    Kumar, N
    Richardson, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S20 - S20
  • [19] Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients
    Weiner, MF
    Martin-Cook, K
    Foster, BM
    Saine, K
    Fontaine, CS
    Svetlik, DA
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (07) : 487 - 492
  • [20] Donepezil in patients with severe alzheimer’s disease
    Karen Marder
    Current Neurology and Neuroscience Reports, 2006, 6 (5) : 363 - 364
12345